LSTA Lisata Therapeutics Company Assets

LSTA (lisata.com) - company brandmark

This chart shows the market price of Lisata Therapeutics (LSTA) total assets on the GURU.Markets platform at 18.09. Lisata Therapeutics is developing the CEND-1 system for pancreatic tumor therapy, aiming to improve the delivery of chemotherapeutic agents. The business model relies on transferring all research to external research networks, which eliminates dependence on specific contractors. Patents for tissue penetration methods and costly tests ensure a high barrier to entry.

LSTA - Lisata Company Total Assets over the range 04/28/2023 - 10/31/2026

Analytical breakdowns and data insights for company lisata.com (LSTA)

- market value and analyst target forecast:
Stock Price Lisata Therapeutics, Inc.|LSTA - Price Target Chart
- market capitalization data:
Market Value Lisata Therapeutics, Inc.|LSTA - Total Company Value
- balance sheet equity data:
Equity per Share Lisata Therapeutics|LSTA - Book Capitalization|Market Cap to Net Assets Ratio lisata.com|LSTA - Aggregate Company Assets
- debt and liquidity details:
Debt to Capital Lisata Therapeutics|LSTA - Long-Term Debt to Equity|Short-Term Debt to Equity Lisata Therapeutics, Inc.|LSTA - Company Debts|Debts to Book Value Lisata Therapeutics, Inc.|LSTA - Company Long-Term Debts|Short-Term Indebtedness Lisata Therapeutics|Immediate Liquidity lisata.com
- earnings and market ratios statistics:
LSTA - Net Income
Basic company analysis:LSTA Lisata
Signature product of Lisata Therapeutics, Inc.

The development of innovative drug delivery methods in tumors by the elite oncologists at Lisata Therapeutics (LSTA) requires significant capital expenditures to navigate clinical phases. This metric, calculated inversely via ROA, determines the current value of all company resources without reporting time lags, allowing investors to track the dynamics of the material base through the value of controlled resources.

Direct competitors

geron.com (GERN) - Company Total Assets|Aggregate Company Assets Nanobiotix|Company Assets Bicycle Therapeutics PLC BCYC|Aggregate Company Assets CytomX Therapeutics Inc (CTMX)|perspectivetherapeutics.com - Total Business Assets|Company Total Assets GNLX (Genelux)|MOLN - Cumulative Company Assets|ONCY - Aggregate Company Assets|Company Assets Moleculin Biotech, Inc.|galeratx.com (GRTX) - Aggregate Company Assets|MTEM (Molecular Templates Corporation) - Aggregate Company Assets